Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$351M |
| 2 |
Netflix
NFLX
|
+$343M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$293M |
| 4 |
Nike
NKE
|
+$186M |
| 5 |
Delta Air Lines
DAL
|
+$177M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$1.33B |
| 2 |
Tesla
TSLA
|
+$344M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$306M |
| 4 |
NVIDIA
NVDA
|
+$281M |
| 5 |
Boeing
BA
|
+$251M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.45% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Aligos Therapeutics
ALGS
$70.9M
| $240K | ﹤0.01% |
12,854
-4,368
| -25% | -$81.6K |
|
3027
Celcuity
CELC
$2.33B
| $239K | ﹤0.01% |
26,156
-4,900
| -16% | -$44.8K |
|
3028
Genworth Financial
GNW
$3.61B
| $239K | ﹤0.01% |
+40,800
| New | +$239K |
|
3029
Clearside Biomedical
CLSD
$25.1M
| $238K | ﹤0.01% |
273,289
-63,400
| -19% | -$55.2K |
|
3030
Astrana Health
ASTH
$1.38B
| $238K | ﹤0.01% |
+7,700
| New | +$238K |
|
3031
Academy Sports + Outdoors
ASO
$3.1B
| $236K | ﹤0.01% |
5,000
-230,200
| -98% | -$10.9M |
|
3032
Cocrystal Pharma
COCP
$16.2M
| $236K | ﹤0.01% |
126,228
+1,700
| +1% | +$3.18K |
|
3033
Comstock
LODE
$143M
| $236K | ﹤0.01% |
57,610
+3,789
| +7% | +$15.5K |
|
3034
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$335M
| $235K | ﹤0.01% |
+4,600
| New | +$235K |
|
3035
SWK Holdings
SWKH
$176M
| $235K | ﹤0.01% |
18,804
+1,893
| +11% | +$23.7K |
|
3036
CI&T Inc
CINT
$696M
| $234K | ﹤0.01% |
+35,959
| New | +$234K |
|
3037
Fulcrum Therapeutics
FULC
$379M
| $234K | ﹤0.01% |
52,734
-292,076
| -85% | -$1.3M |
|
3038
Golden Entertainment
GDEN
$638M
| $234K | ﹤0.01% |
6,850
-10,446
| -60% | -$357K |
|
3039
Vanguard Mid-Cap Growth ETF
VOT
$17.8B
| $234K | ﹤0.01% |
1,200
-3,700
| -76% | -$722K |
|
3040
Similarweb
SMWB
$857M
| $233K | ﹤0.01% |
35,900
+300
| +0.8% | +$1.95K |
|
3041
Fate Therapeutics
FATE
$111M
| $232K | ﹤0.01% |
109,219
-563,097
| -84% | -$1.2M |
|
3042
ReNew
RNW
$2.76B
| $232K | ﹤0.01% |
42,800
-35,700
| -45% | -$194K |
|
3043
Jerash Holdings
JRSH
$44.1M
| $231K | ﹤0.01% |
76,240
-7,808
| -9% | -$23.7K |
|
3044
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$1.87B
| $230K | ﹤0.01% |
+4,000
| New | +$230K |
|
3045
Legacy Housing
LEGH
$657M
| $227K | ﹤0.01% |
11,700
+2,000
| +21% | +$38.8K |
|
3046
Pulmatrix
PULM
$18.3M
| $226K | ﹤0.01% |
111,265
+2,253
| +2% | +$4.58K |
|
3047
Schwab US Large-Cap Growth ETF
SCHG
$49.5B
| $225K | ﹤0.01% |
12,400
-51,200
| -81% | -$929K |
|
3048
Cytosorbents Corp
CTSO
$58.9M
| $224K | ﹤0.01% |
119,100
+200
| +0.2% | +$376 |
|
3049
SPDR S&P Aerospace & Defense ETF
XAR
$4.05B
| $224K | ﹤0.01% |
2,000
-200
| -9% | -$22.4K |
|
|
SFT
3050
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $224K | ﹤0.01% |
140,172
-58,800
| -30% | -$94K |
|